1. Methotrexate enhances 3T3-L1 adipocytes hypertrophy
- Author
-
Rosário Monteiro, Ana Paula Cunha, Conceição Calhau, Ana Faria, Cláudia Marques, Elisa Keating, Manuela Meireles, Diana Teixeira, Diogo Pestana, Faculdade de Medicina, and Faculdade de Ciências
- Subjects
medicine.medical_specialty ,Cell Survival ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,Glucose uptake ,Sulforhodamine B ,Adipose tissue ,Toxicology ,Cell Line ,Arthritis, Rheumatoid ,Mice ,chemistry.chemical_compound ,Health sciences, Basic medicine ,Internal medicine ,Basic medicine [Medical and Health sciences] ,Adipocytes ,medicine ,Animals ,Insulin ,Obesity ,Cell Proliferation ,Metabolic Syndrome ,Adipogenesis ,business.industry ,Medicina básica [Ciências médicas e da saúde] ,Biological Transport ,Cell Differentiation ,3T3-L1 ,3T3 Cells ,Cell Biology ,Lipid Metabolism ,medicine.disease ,Glucose ,Methotrexate ,Endocrinology ,chemistry ,Folic Acid Antagonists ,Ciências da Saúde, Medicina básica ,Metabolic syndrome ,business ,medicine.drug - Abstract
Methotrexate (MTX) is broadly used in the treatment of chronic inflammatory diseases such as rheumatoid arthritis (RA). The prevalence of metabolic syndrome (MeS) in patients with this condition is relatively high. Given the importance of adipose tissue in the development of obesity metabolic complications, this study aimed to investigate the effect of methotrexate on preadipocyte proliferation, adipogenesis, and glucose uptake by adipocytes. 3T3-L1 preadipocytes proliferation was evaluated by sulforhodamine B staining and H-3-thymidine incorporation, after 24 or 48 h of treatment with MTX (0.1 and 10 mu M). Preadipocytes were induced to differentiate with an appropriate adipogenic cocktail in the presence or absence of MTX. Adipogenesis was determined by measuring lipid accumulation after staining with oil red O. H-3-Deoxyglucose (H-3-DG) uptake was determined by liquid scintillation counting. MTX treatment reduced culture protein content in a concentration-dependent manner and H-3-thymidine incorporation (P < 0.05). MTX (0.1 mu M) treatment increased lipid accumulation and basal H-3-DG uptake by adipocytes (P < 0.05). In 0.1 mu M MTX-treated adipocytes, insulin stimulation did not result in an increase of H-3-DG uptake, contrarily to what was observed in control cells. These results demonstrate that methotrexate interferes with adipocyte proliferation and promotes the hypertrophic growth of adipocytes. These molecular effects may have implications on metabolic profile of RA patients treated with MTX.
- Published
- 2013
- Full Text
- View/download PDF